Baihua Pharmaceutical (600721.SH): Planning for changes in controlling rights, stock trading suspended.

Intelligence Financial News App News, Baohua Medicine (600721.SH) announced that the company received a notice from the company's controlling shareholder and actual controller Mr. Mi Zaiqi, Mr. Mi Enhua, and Ms. Yang Xiaoling on December 26, 2025, that they are planning for the transfer of the company's equity agreement. This matter may result in a change in the company's controlling rights. The company's stock will be suspended from trading starting on December 29, 2025 (Monday), and the expected suspension period will not exceed 2 trading days.